Edwards Lifesciences Share Dilution Ratio Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 108.25  0.27  0.25%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Share Dilution Ratio of Edwards Lifesciences Corporation with missing and latest data points interpolated. Measures the ratio between Weighted Average Shares Diluted and Weighted Average Shares.
Share Dilution Ratio  10 Years Trend  
Decreasing
Slightly volatile
 Share Dilution Ratio 
      Timeline 

Edwards Lifesciences Share Dilution Ratio Over Time

2015-12-31  1.02 
2016-12-31  1.02 
2017-12-31  1.07 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  1.04
Geometric Mean  1.04
Coefficient Of Variation  2.33
Mean Deviation  0.018594
Median  1.04
Standard Deviation  0.024286
Sample Variance  0.00058979
Range  0.075462
R Value (0.42)
Mean Square Error  0.00053661
R Squared  0.17
Significance  0.18
Slope (0.0028)
Total Sum of Squares  0.006488

Currently Trending

S   
 NYQ 
Purchased over 400 shares of
few hours ago ago
Traded for 7.12
GM   
 NYQ 
Purchased over 60 shares of
few hours ago ago
Traded for 45.88
MSFT   
 NMS 
Purchased over 30 shares of
few hours ago ago
Traded for 77.49